Annika Teleman

862 total citations
17 papers, 631 citations indexed

About

Annika Teleman is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Annika Teleman has authored 17 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 10 papers in Hematology and 4 papers in Immunology. Recurrent topics in Annika Teleman's work include Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Spondyloarthritis Studies and Treatments (7 papers). Annika Teleman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Spondyloarthritis Studies and Treatments (7 papers). Annika Teleman collaborates with scholars based in Sweden and Romania. Annika Teleman's co-authors include Per Larsson, Elke Theander, Ulla Lindqvist, Mats Geijer, Gerd-Marie Alenius, Tomas Husmark, J Theander, Ronald van Vollenhoven, Barbro Arvidsson and L Cöster and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Journal of Advanced Nursing.

In The Last Decade

Annika Teleman

16 papers receiving 620 citations

Peers

Annika Teleman
Comparison fields: 5 of 52
  • Rheumatology 577
  • Hematology 271
  • Immunology 218
  • Genetics 95
  • Pathology and Forensic Medicine 70
Replace U. von Hinüber with:
U. von Hinüber Germany
D Hofman Netherlands
E Rødevand Norway
Aatke van der Maas Netherlands
Fedra Irazoque-Palazuelos Mexico
Tom Sheeran United Kingdom
Carlos Rodríguez‐Lozano Spain
Sabrina Rebello United States
M Schneider Germany
Constance Hammond United States
U. von Hinüber Germany View profile →
Citations per field, relative to Annika Teleman
Annika Teleman · 1×
Citations per year, relative to Annika Teleman
Annika Teleman · 1×

Countries citing papers authored by Annika Teleman

Since Specialization
Citations

This map shows the geographic impact of Annika Teleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Teleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Teleman more than expected).

Fields of papers citing papers by Annika Teleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Teleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Teleman. The network helps show where Annika Teleman may publish in the future.

Co-authorship network of co-authors of Annika Teleman

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Teleman. A scholar is included among the top collaborators of Annika Teleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Teleman. Annika Teleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 0
2
DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.
5
3 32
4 34
5 62
6 3
7
Rheumatoid Arthritis, a More Severe Disease Than Psoriatic Arthritis? : A Comparison Of Disease Activity In Patients With Psoriatic Arthritis and Rheumatoid Arthritis From The Swedish Early Psoriatic Arthritis Registry (SwePsA) and The Swedish Rheumatology Registry For Early Rheumatoid Arthritis (SRR)
2
8 136
9 45
10
A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission
12
11 4
12 1
13
The Swedish Early Psoriatic Arthritis (SwePsA) Registry. 5-Year Follow-up : Higher Disease Activity, Greater Functional Impairment and Worse Outcome for Women Compared to Men
2
14 19
15 224
16
Patient-reported swollen and tender 28-joint counts accurately represent RA disease activity and can be used to calculate DAS28 on a group level
1
17 49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026